Cargando…

Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers

OBJECTIVES: The objective of this study was to carry out a head-to-head comparison of topical sucralfate combined with mupirocin versus mupirocin alone in the treatment of chronic skin ulcers with respect to both effectiveness and safety. MATERIALS AND METHODS: A parallel-group, open-label, randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Subhrangsu, Sen, Sumit, Hazra, Avijit, Das, Amal Kanti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892012/
https://www.ncbi.nlm.nih.gov/pubmed/31831920
http://dx.doi.org/10.4103/ijp.IJP_237_17
_version_ 1783475945613557760
author Chatterjee, Subhrangsu
Sen, Sumit
Hazra, Avijit
Das, Amal Kanti
author_facet Chatterjee, Subhrangsu
Sen, Sumit
Hazra, Avijit
Das, Amal Kanti
author_sort Chatterjee, Subhrangsu
collection PubMed
description OBJECTIVES: The objective of this study was to carry out a head-to-head comparison of topical sucralfate combined with mupirocin versus mupirocin alone in the treatment of chronic skin ulcers with respect to both effectiveness and safety. MATERIALS AND METHODS: A parallel-group, open-label, randomized, controlled trial (CTRI/2015/12/006443) was carried out with patients suffering from skin ulcers of Wagner grading 1 or 2 persisting for over 4 weeks. Ninety-six patients were recruited in total, and the modified intention-to-treat analysis dataset included 44 participants treated with mupirocin 2% and 46 treated with combined mupirocin 2% and sucralfate 7% ointment. Both medications were applied topically thrice daily for 6 weeks. Ulcer area assessed using millimeter graph paper and wound infection score assessed on a three-point scale were effectiveness measures. Treatment-emergent adverse reactions that were reported by patients or observed by the investigators were recorded. RESULTS: The median ulcer area was significantly reduced in the combined treatment group at the end of treatment. Clinically, 41.3% of the participants in the combined group showed complete ulcer healing at 6 weeks compared to 18.18% in the mupirocin alone group (P = 0.022). The wound infection score declined significantly from baseline by the end of 3 weeks of treatment in both the groups. The frequency of qualitative wound attributes, namely pain, discharge, and erythema, remained comparable between the groups except for discharge which disappeared completely from all remaining ulcers in the combined group but was still present in 11.36% of the participants treated with mupirocin alone (P = 0.025) at 6 weeks. Adverse events were few, all local, mild, and tolerable. CONCLUSIONS: The wound healing effect of topical sucralfate adds to the antimicrobial effect of mupirocin toward the overall improvement of chronic skin ulcers. The effect of combined topical treatment needs comparison with other topical medications and wound healing strategies.
format Online
Article
Text
id pubmed-6892012
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-68920122019-12-12 Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers Chatterjee, Subhrangsu Sen, Sumit Hazra, Avijit Das, Amal Kanti Indian J Pharmacol Research Article OBJECTIVES: The objective of this study was to carry out a head-to-head comparison of topical sucralfate combined with mupirocin versus mupirocin alone in the treatment of chronic skin ulcers with respect to both effectiveness and safety. MATERIALS AND METHODS: A parallel-group, open-label, randomized, controlled trial (CTRI/2015/12/006443) was carried out with patients suffering from skin ulcers of Wagner grading 1 or 2 persisting for over 4 weeks. Ninety-six patients were recruited in total, and the modified intention-to-treat analysis dataset included 44 participants treated with mupirocin 2% and 46 treated with combined mupirocin 2% and sucralfate 7% ointment. Both medications were applied topically thrice daily for 6 weeks. Ulcer area assessed using millimeter graph paper and wound infection score assessed on a three-point scale were effectiveness measures. Treatment-emergent adverse reactions that were reported by patients or observed by the investigators were recorded. RESULTS: The median ulcer area was significantly reduced in the combined treatment group at the end of treatment. Clinically, 41.3% of the participants in the combined group showed complete ulcer healing at 6 weeks compared to 18.18% in the mupirocin alone group (P = 0.022). The wound infection score declined significantly from baseline by the end of 3 weeks of treatment in both the groups. The frequency of qualitative wound attributes, namely pain, discharge, and erythema, remained comparable between the groups except for discharge which disappeared completely from all remaining ulcers in the combined group but was still present in 11.36% of the participants treated with mupirocin alone (P = 0.025) at 6 weeks. Adverse events were few, all local, mild, and tolerable. CONCLUSIONS: The wound healing effect of topical sucralfate adds to the antimicrobial effect of mupirocin toward the overall improvement of chronic skin ulcers. The effect of combined topical treatment needs comparison with other topical medications and wound healing strategies. Wolters Kluwer - Medknow 2019 2019-11-26 /pmc/articles/PMC6892012/ /pubmed/31831920 http://dx.doi.org/10.4103/ijp.IJP_237_17 Text en Copyright: © 2019 Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Article
Chatterjee, Subhrangsu
Sen, Sumit
Hazra, Avijit
Das, Amal Kanti
Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers
title Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers
title_full Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers
title_fullStr Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers
title_full_unstemmed Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers
title_short Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers
title_sort randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892012/
https://www.ncbi.nlm.nih.gov/pubmed/31831920
http://dx.doi.org/10.4103/ijp.IJP_237_17
work_keys_str_mv AT chatterjeesubhrangsu randomizedcontrolledtrialoftopicalmupirocinversusmupirocinwithsucralfatecombinationinchronicskinulcers
AT sensumit randomizedcontrolledtrialoftopicalmupirocinversusmupirocinwithsucralfatecombinationinchronicskinulcers
AT hazraavijit randomizedcontrolledtrialoftopicalmupirocinversusmupirocinwithsucralfatecombinationinchronicskinulcers
AT dasamalkanti randomizedcontrolledtrialoftopicalmupirocinversusmupirocinwithsucralfatecombinationinchronicskinulcers